UnknownNot Applicable

Neuroimaging in Acute Stroke

Czechia500 participantsStarted 2023-05-01

Plain-language summary

The main aim of this study is to identify the predictive value of CT parameters (e-ASPECTS, CTP, collateral vessel status, volume, and location of ischemic lesion volume) at a 3-month functional outcome defined by the modified Rankin scale (mRS) in patients with non-lacunar stroke after recanalization treatment (Intravenous Thrombolytic Therapy and/or Mechanical Thrombectomy, or conservative treatment).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute ischemic stroke within 12 hours of onset, treated with intravenous thrombolysis and/or mechanical thrombectomy or conservatively. * Unknown time of onset of ischemic stroke. * Wake-up stroke (with symptoms of stroke since awakening). Exclusion Criteria: * Pre-event modified Rankin Scale (mRS) score \> 4 points. * Acute haemorrhagia or other NCCT finding excluding dg. ischemic stroke.

What they're measuring

Modified Rankin Scale

Timeframe: 3 months

Trial details

NCT IDNCT05864495

SponsorUniversity Hospital Ostrava

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

Contact for this trial

Jiří Hynčica

0042059737 jiri.hyncica@fno.cz

View on ClinicalTrials.gov More Stroke, Acute trials